Affidea, a European healthcare provider with more than 240 locations, announced it is now implementing Subtle Medical’s SubtlePET solution in its PET-CT center in Italy.

Drug prices are on the move upward once again in 2020, according to new data from 3 Axis Advisors.

Microbot Medical, a Hingham, Massachusetts-based healthcare technology company, has announced plans to debut a fully disposable robotic system to be used during neurovascular, cardiovascular and peripheral vascular procedures.

Deep-learning based AI models can identify breast cancer more accurately than radiologists, according to new research published in Nature. What does this mean for the future of cancer detection?

Hospital acquisitions may have a negative impact on the quality of patient care, according to new findings published in the New England Journal of Medicine. The study results may help answer the question of how mergers and acquisitions impact patients and quality of care.

One out-of-this-world use for AI involves measuring the body compositions of astronauts.

AI in Healthcare spent 2019 tracking the steady evolution of AI and other advanced technologies, paying close attention to how they could change patient care forever. We’ve gathered 10 of the site’s most popular—and compelling—articles from the past 12 months.

President Trump signed the latest $1.4 trillion spending bills into law to fund the government and simultaneously gutted three taxes related to the Affordable Care Act: the health insurance tax, Cadillac tax and medical device tax.

Electronic medical record products may have patient safety issues––even if they’re certified, according to a new study published in JAMA.

Novartis may give away a new drug with a price tag above $2 million for free to some patients using a lottery-style program. The drug, Zolgensma, is a cure for a deadly inherited disease, spinal muscular atrophy, and the world’s most expensive drug.